Yuhang
Xu
a,
Qian
Liu
ab,
Bin
Wang
ac,
Quan
Li
a,
Yue
Chen
a,
Yao
Yang
a,
Zhihao
Zhu
a,
Daohui
Gong
a,
Chuan
Zhang
*d,
Guansong
Wang
*ac and
Hang
Qian
*ac
aInstitute of Respiratory Diseases, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China. E-mail: hqian@tmmu.edu.cn; wanggs@tmmu.edu.cn
bLaboratory of Pharmacy and Chemistry, and Laboratory of Tissue and Cell Biology, Lab Teaching & Management Center, Chongqing Medical University, Chongqing, 400016, China
cChongqing Key Laboratory of Precision Medicine and Prevention of Major Respiratory Diseases, Chongqing 400037, China
dSchool of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China
First published on 29th October 2024
Correction for ‘Tobramycin-mediated self-assembly of DNA nanostructures for targeted treatment of Pseudomonas aeruginosa-infected lung inflammation’ by Yuhang Xu et al., Biomater. Sci., 2024, 12, 2331–2340, https://doi.org/10.1039/D3BM02121A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2024 |